CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-17
DOI
10.1002/anie.202005362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Multiaction and Multitarget Ru(II)-Pt(IV) Conjugate Combining Cancer Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
- (2020) Johannes Karges et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
- (2019) Reece G. Kenny et al. CHEMICAL REVIEWS
- Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
- (2019) Tiantian Fang et al. Nature Communications
- Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
- (2019) Maria V. Babak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Organic Photodynamic Nanoinhibitor for Synergistic Cancer Therapy
- (2019) Yuyan Jiang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeted photoredox catalysis in cancer cells
- (2019) Huaiyi Huang et al. Nature Chemistry
- New power of self-assembling carbonic anhydrase inhibitor: Short peptide–constructed nanofibers inspire hypoxic cancer therapy
- (2019) Jiayang Li et al. Science Advances
- Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug
- (2018) Lili Ma et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
- (2018) Elisabetta Gabano et al. DALTON TRANSACTIONS
- Stimuli-Responsive Therapeutic Metallodrugs
- (2018) Xiaohui Wang et al. CHEMICAL REVIEWS
- Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach
- (2017) Hyo Sung Jung et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models
- (2017) Simone Göschl et al. Metallomics
- A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
- (2016) Zhigang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation
- (2016) Ekaterina Schreiber-Brynzak et al. Metallomics
- Carbonic anhydrase IX inhibitors in cancer therapy: an update
- (2015) Claudiu T Supuran et al. Future Medicinal Chemistry
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs
- (2015) Daniel Yuan Qiang Wong et al. Chemical Science
- Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
- (2015) Yao-Rong Zheng et al. Chemical Science
- Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models
- (2015) Carol Ward et al. Oncotarget
- Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
- (2014) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- [(Cp-R)M(CO)3] (M=Re or 99mTc) Arylsulfonamide, Arylsulfamide, and Arylsulfamate Conjugates for Selective Targeting of Human Carbonic Anhydrase IX
- (2012) Daniel Can et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting and delivery of platinum-based anticancer drugs
- (2012) Xiaoyong Wang et al. CHEMICAL SOCIETY REVIEWS
- Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
- (2009) Giuseppina De Simone et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More